University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

FIGO good practice recommendations on modifiable causes of iatrogenic preterm birth

dc.contributor.authorValencia, Catalina M.
dc.contributor.authorMol, Ben W.
dc.contributor.authorJacobsson, Bo
dc.contributor.authorFIGO Working Group for Preterm Birth
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Women’s Health Researchen
dc.date.accessioned2021-10-06T20:32:01Z
dc.date.available2021-10-06T20:32:01Z
dc.date.issued2021-10-01
dc.descriptionFunding Information: Catalina M. Valencia reports no conflicts of interest. Ben W. Mol reports an investigator grant from NHMRC; consultancy for ObsEva; and research funding from Guerbet, Ferring, and Merck KGaA. Bo Jacobbson reports research grants from Swedish Research Council, Norwegian Research Council, March of Dimes, Burroughs Wellcome Fund and the US National Institute of Health; clinical diagnostic trials on NIPT with Ariosa (completed), Natera (ongoing), Vanadis (completed) and Hologic (ongoing) with expendidures reimbused per patient; clinical probiotic studies with product provided by FukoPharma (ongoing, no funding) and BioGaia (ongoing; also provided a research grant for the specific study); collaboration in IMPACT study where Roche, Perkin Elmer and Thermo Fisher provided reagents to PLGF analyses; coordination of scientific conferences and meetings with commercial partners as such as NNFM 2015, ESPBC 2016 and a Nordic educational meeting about NIPT and preeclampsia screening. Bo Jacobbson is also Chair of the FIGO Working Group for Preterm Birth and the European Association of Perinatal Medicine's special interest group of preterm delivery; steering group member of Genomic Medicine Sweden; chairs the Genomic Medicine Sweden complex diseases group; and is Swedish representative in the Nordic Society of Precision Medicine.en
dc.description.statusPeer revieweden
dc.format.extent5
dc.format.extent470539
dc.identifier201501873
dc.identifier8600e1e8-b8fe-4d9b-8889-21fb7c15d0c8
dc.identifier85115062482
dc.identifier.citationValencia, C M, Mol, B W, Jacobsson, B & FIGO Working Group for Preterm Birth 2021, 'FIGO good practice recommendations on modifiable causes of iatrogenic preterm birth', International Journal of Gynecology and Obstetrics, vol. 155, no. 1, pp. 8-12. https://doi.org/10.1002/ijgo.13857en
dc.identifier.doi10.1002/ijgo.13857
dc.identifier.iss1en
dc.identifier.issn0020-7292
dc.identifier.urihttps://hdl.handle.net/2164/17276
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85115062482&partnerID=8YFLogxKen
dc.identifier.vol155en
dc.language.isoeng
dc.relation.ispartofInternational Journal of Gynecology and Obstetricsen
dc.subjectelective deliveryen
dc.subjectiatrogenic preterm birthen
dc.subjectmodifiable causesen
dc.subjectR Medicineen
dc.subjectObstetrics and Gynaecologyen
dc.subject.lccRen
dc.titleFIGO good practice recommendations on modifiable causes of iatrogenic preterm birthen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Valencia_etal_GO_FIGO_good_practice_VOR.pdf
Size:
459.51 KB
Format:
Adobe Portable Document Format

Collections